24 results
6-K
EX-5.2
PRTG
Portage Biotech Inc
3 Oct 23
Current report (foreign)
4:05pm
, conscionability and materiality (regardless of whether the Securities are considered in a proceeding in equity or at law), including, without limitation
6-K
EX-10.1
PRTG
Portage Biotech Inc
3 Oct 23
Current report (foreign)
4:05pm
are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties … material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects
6-K
EX-2.1
PRTG
Portage Biotech Inc
8 Jul 22
Current report (foreign)
8:58am
or any ancillary agreement or (as such representation or warranty would read if all qualifications as to materiality, including each reference
6-K
EX-10.3
dvdzds2 n8he4
8 Jul 22
Current report (foreign)
8:58am
20-F/A
c6yv0sgbevz 961x
3 Mar 22
Annual report (foreign) (amended)
6:57pm
6-K
EX-99.1
gp1ec1bpf 78m70
3 Mar 20
Consolidated Interim Financial Statements
12:00am
6-K
EX-99.1
3mtpaksrx6 8fph
19 Feb 19
Report of Foreign Private Issuer
10:37am
6-K
1cqsrimj
6 Jul 12
Amended and Restated Settlement Agreement June 29, 2012
12:00am
424B3
uef1nu3ows4lkfplz 73
9 Jan 12
Prospectus supplement
12:00am
424B3
zd60c9s a5
9 Jan 12
Prospectus supplement
12:00am
6-K
3072l
6 Jan 12
Settlement Agreement
12:00am